InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Filip Janku. Director active across 2 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. Activity tracked since 23 June 2026. The latest transaction was disclosed on 30 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条